AFEW International reports that although harm reduction and health organisations are adapting to pandemic restrictions, the continuity of prevention and treatment remains affected.
Transform and MUCD compare different aspects of regulation models in Canadian provinces, including licences, retail stores, age restrictions, prices, home-growing and remaining social inequalities.
Irvine et al. found that take‐home naloxone kits, supervised consumption sites and opioid agonist therapy have been effective in averting overdose deaths in British Columbia.
Unlu et al. argue that the impact of decriminalisation is heavily mediated by contextual factors, including investment in harm reduction and law enforcement involvement.
AIN states that by addressing the underlying causes of coca cultivation, collaborative coca crop reductions in Bolivia proved to be more sustainable than those achieved under forced eradication.
Monash University, ADPAN and HRI demonstrate how the current Malaysian death penalty framework do not meet fair trial standards and outline significant socio-economic, nationality and language barriers.
EMCDDA and Europol found that the pandemic is leading to shortages and higher prices, although the disruptions vary greatly between countries and substances.
